老虎證券

美股詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Aurinia Pharmaceuticals Inc

7.89
+0.23003.00%
盤前：7.71-0.1800-2.28%04:16 EDT
成交量：104.70萬
成交額：823.30萬
市值：10.84億
市盈率：197.25
高：7.92
開：7.77
低：7.75
收：7.66
資料載入中...
總覽公司新聞公告
2021/02/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/24

重要事件披露

8-K - Current report
2021/02/17

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/27

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/25

重要事件披露

8-K - Current report
2020/10/09

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/11

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/11

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/07/23

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/03/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

年度報告

Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
更多